The answer to this question can, at its simplest, be achieved by the analysis of data at two timepoints; baseline (prior to initiation of therapy) and one additional timepoint, some days, weeks or months later, when the pharmacokinetics and pharmacodynamics of the drug indicate it should have reached peak efficacy. In reality, longer-term trials ar...

Therapeutic Success or Failure: A Journey, Not Just a Destination